IL17A and Alzheimer disease: In mouse models, hippocampal injection of Aβ to induce AD-related changes leads to BBB disruption and Th17 cell infiltration, accompanied by the overexpression of proinflammatory cytokines such as IL-17 and IL-22, contributing to neurodegeneration [45].